Table 2.
Characteristics | Number of patients | Mean ± SD | P value |
---|---|---|---|
Age (year) | |||
≥60 | 14 | 16.88 ± 0.644 | 0.145 |
<60 | 26 | 15.52 ± 0.572 | |
Gender | |||
Male | 28 | 16.05 ± 0.537 | 0.871 |
Female | 12 | 15.89 ± 0.813 | |
Tumor size(cm) | |||
≥5 | 6 | 13.43 ± 0.543 | 0.0125∗ |
<5 | 34 | 16.45 ± 0.408 | |
Differentiation | |||
Well and moderate | 34 | 16.23 ± 0.424 | 0.221 |
Poor | 6 | 14.70 ± 0.747 | |
T stage | |||
T1–2 | 29 | 16.58 ± 0.45 | 0.0317∗ |
T3–4 | 11 | 14.47 ± 0.99 | |
TNM | |||
I and II | 19 | 16.76 ± 0.61 | 0.103 |
III and IV | 21 | 15.31 ± 0.61 | |
Lymphatic metastasis | |||
N0 | 24 | 16.50 ± 0.516 | 0.170 |
N1–3 | 16 | 15.25 ± 0.773 |
∗ indicated statistical significance.